Keywords: اینترلوکین 17; BMI; Body Mass Index; IFN-g; Interferon gamma; IL; Interleukins; SANS; Scale for Assessment of Negative Symptoms; SAPS; Scale for Assessment of Positive Symptoms; TNF; Tumor necrosis factor; Schizophrenia; Interleukin-6; Interleukin-17; Immune pathogenesi
مقالات ISI اینترلوکین 17 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترلوکین 17; Stromal cell-derived factor-1; Primary biliary cholangitis; Interleukin-17; Diagnostic performance;
Keywords: اینترلوکین 17; Interleukin-17; Atherosclerosis; Cardiovascular diseases;
Keywords: اینترلوکین 17; ATG; autophagy-related proteins; CMA; chaperone-mediated autophagy; ULK1; Unc-51-like kinase 1; PI3K; phosphatidylinositol 3-kinase; mTOR; mammalian target of rapamycin; PE; phosphatidylethanolamine; IFN-γ; interferon-γ; IL-1; interleukin-1; IL-17; inte
Keywords: اینترلوکین 17; BD; bipolar disorder; IL-17; interleukin-17; YMRS; young mania rating scale; HDRS; hamilton depression rating scale; CSSR; Columbia suicide severity rating scale; DSM-IV TR; diagnostic and statistical manual of mental disorders, edition IV-text revised;
Keywords: اینترلوکین 17; ACQ; asthma control questionnaire; AHR; airway hyperresponsiveness; Anti-IL5; anti-interleukin 5; AQLQ; asthma quality of life questionnaire; ASM; airway smooth muscle; BAL; bronchoalveolar lavage; BT; Bronchial Thermoplasty; ECM; extracellular matrix; ED
Keywords: اینترلوکین 17; LM; light microscopy; ROS; reactive oxygen species; TBARS; thiobarbituric acid reactive substances; TEM; transmission electron microscopy; SEM; scanning electron microscopy; EDX; energy dispersive X-ray analyser; AFM; atomic force microscopy; Fluoride tox
Keywords: اینترلوکین 17; Diabetes; Endodontic infection; Apical periodontitis; Interleukin-17;
Keywords: اینترلوکین 17; Bronchiectasis; Inflammation; Acute-phase reaction; Fibrinogen; Interleukin-17;
Keywords: اینترلوکین 17; anti-CCP; anti-cyclic citrullinated peptide antibody; BMI; body mass index; CCL20; CC chemokine ligand 20; C/EBPβ; CCAAT-enhancer-binding protein β; CRP; C-reactive protein; CSF1R; colony stimulating factor 1 receptor; DAS28; disease activity score 28;
Keywords: اینترلوکین 17; Hypogonadism; Biomarkers; Cardiovascular Diseases; Troponin I; Endothelin-1; Interleukin-6; Tumor Necrosis Factor-α; Interleukin-17; Pro-Brain Natriuretic Peptide; Leptin;
Keywords: اینترلوکین 17; Anti-IL-17 agents; Interleukin-17; Ixekizumab; Psoriasis; Agentes anti IL-17; Interleucina-17; Ixekizumab; Psoriasis;
Keywords: اینترلوکین 17; bone marrow stem cells; Cyclooxygenase-2; engraftment; interleukin-17; inflammation; nuclear factor kappa B; re-epithelialization; transplantation; wound repair;
Keywords: اینترلوکین 17; AS; Angeli's salt; AST; aspartate aminotransferase; ALT; alanine transaminase; BALF; bronchoalveolar lavage fluid; CGRP; calcitonin gene-related peptide; COX-2; cyclooxygenase-2; CFU; colony-forming unity; cGMP; cyclic guanosine monophosphate; PKG; cGMP-d
Keywords: اینترلوکین 17; WHO; World Health Organization; Ppm; part per million; EPA; Environmental Protection Agency; BIS; Bureau of Indian Standards; ICMR; Indian Council of Medical Research; IS; Indian Standards; CF; carbon-fluoride; PGI2; prostacyclin; GABA; gamma-aminobutyric
Keywords: اینترلوکین 17; Interleukin-1; Interleukin-15; Interleukin-17; Monocyte chemotactic protein-1; Endothelial dysfunction; Osteoarthritis;
Keywords: اینترلوکین 17; Interleukin-17; Allergy; Streptococcus pneumoniae; Airway inflammation;
Keywords: اینترلوکین 17; Keratin 10; Keratin 17; Transmission electron microscopy; Interleukin-17; Tumor necrosis factor alpha;
Keywords: اینترلوکین 17; Interleukin-17; Interleukin-22; Septic shock; Acute kidney injury; Outcome;
Keywords: اینترلوکین 17; Cyr61; cysteine-rich protein 61; RA; rheumatoid arthritis; IL-17; interleukin-17; ECM; extracellular matrix; CTGF; connective tissue growth factor; IGFBP; insulin-like growth factor binding protein domain; VWC; von Willebrand type C repeat; TSP-1; thrombo
Keywords: اینترلوکین 17; Rheumatoid arthritis; Interleukin-37; Interleukin-17; Interleukin-6
Keywords: اینترلوکین 17; Angiogenesis; Inflammation; Interleukin-17; Preeclampsia; Pregnancy; Th17;
Keywords: اینترلوکین 17; IL17; interleukin-17; SNPs; single nucleotide polymorphisms; IL17R; interleukin-17 receptor; PTC; papillary thyroid carcinoma; MMPs; metalloproteinases; Th17; T helper 17; TNF; tumor necrosis factor; PCR; polymerase chain reaction; PBMCs; peripheral blood
Keywords: اینترلوکین 17; Interleukin-17; Autoimmune diseases; Biological agents;
Keywords: اینترلوکین 17; Psoriatic arthritis; Synovitis; Dactylitis; Enthesitis; Joint; Osteoclastogenesis; Interleukin-17;
Keywords: اینترلوکین 17; autoimmune diseases; inflammation; arthritis; inflammatory bowel diseases; translational medical research; ANR; French National Research Agency (Agence nationale de la recherche); AVIESAN; French National Alliance for Life Sciences and Health (Alliance po
Keywords: اینترلوکین 17; DILI; drug-induced liver injury; IL-17; interleukin-17; Th17 cells; T helper 17 cells; TP; triptolide; TWHF; Tripterygium wilfordii Hook F; Treg; regulatory T cells; T-bet; T-box expressed in T cells; GATA-3; GATA-binding domain-3; FoxP3; Forkhead box P3;
Keywords: اینترلوکین 17; Neuropathic pain; Interleukin-17; Inflammation; Nerve injury; Animal model;
Keywords: اینترلوکین 17; Atherosclerosis; Cardiovascular; Cardiovascular disease; Inflammation; Inflammatory pathway; Interleukin-17; Metabolic syndrome; Psoriasis;
Keywords: اینترلوکین 17; Interleukin-17; Inflammation; Horse; Cattle; Swine;
Keywords: اینترلوکین 17; EGF; epidermal growth factor; FGF-2; fibroblast growth factor-2; Flt3-L; Fms-related tyrosine kinase 3-ligand; GCSF; granulocyte colony stimulating factor; GMCSF; granulocyte monocyte colony stimulating factor; IFN-γ; interferon-γ; IL-1α; interleukin-1
Keywords: اینترلوکین 17; Stroke; Ischemia; Inflammation; Cytokine; Interleukin-17; Th17; Gamma delta T cell; Immunity; Neurodegeneration;
Keywords: اینترلوکین 17; Interleukin-17; Interleukin-10; Suppressor of cytokine signaling-3; AIDS; Human cytomegalovirus;
Keywords: اینترلوکین 17; Otitis media; Mucosal immunity; Innate immunity; Haemophilus influenzae; Interleukin-17; Interleukin-22
NLRP3 inflammasomes and NLRP3 inflammasome-derived proinflammatory cytokines in peripheral blood mononuclear cells of patients with ankylosing spondylitis
Keywords: اینترلوکین 17; Ankylosing spondylitis; NLRP3; Inflammasome; Interleukin-1β; Interleukin-17;
Dexmedetomidine mitigate acute lung injury by inhibiting IL-17-induced inflammatory reaction
Keywords: اینترلوکین 17; IL-17; interleukin-17; TNF; tumor necrosis factor; Dex; dexmedetomidine; TRAF; tumor necrosis factor receptor-associated factor; Dexmedetomidine; IL-17; Lung injury; Inflammation; NF-κB;
The regulatory role of Nrf2 in antioxidants phase2 enzymes and IL-17A expression in patients with ulcerative colitis
Keywords: اینترلوکین 17; ROS; reactive oxygen species; UC; ulcerative colitis; Nrf2; nuclear factor erythroid 2 related factor 2; IBD; inflammatory bowel diseases; DSS; dextran sodium sulfate; IL-17; interleukin-17; APE1; apurinic/apyrimidinic endonuclease; PRDX1; peroxiredoxin-1
Kuijieling regulates the differentiation of Treg and Th17 cells to ameliorate experimental colitis in rats
Keywords: اینترلوکین 17; UC; ulcerative colitis; KJL; Kuijieling; Tregcells; regulatory T cells; Th17cells; T helper 17 cells; Foxp3; forkhead box P3; RORγt; retinoic acid-related orphan receptor γt; TGF-β1; transforming growth factor-β1; IL; interleukin; STAT; signal transdu
Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways
Keywords: اینترلوکین 17; Resolvin D1; Keratinocyte; Psoriasis; Inflammation; MAPKs; Boc; tert-butoxycarbonyl Met-Leu-Phe peptide; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; IL-17; interleukin-17; IL-22; interleukin-22; IL-23; interleukin-23; IMQ; imiquimod; MAPKs; mitogen-a
Exposure to formaldehyde and diisononyl phthalate exacerbate neuroinflammation through NF-κB activation in a mouse asthma model
Keywords: اینترلوکین 17; DAB; diaminobenzidine; DCFH-DA; 2â², 7â²-dichlorodihydrofluorescein; DHMEQ; dehydroxymethylepoxyquinomicin; DINP; diisononyl phthalate; ECP; eosinophil cationic protein; FA; formaldehyde; H&E; hematoxylin and eosin; IL-17; interleukin-17; IL-1β; interl
Hyaluronan in experimental injured/inflamed cartilage: In vivo studies
Keywords: اینترلوکین 17; ACAN; aggrecan; ADAMTS-5; A disintegrin and metalloproteinase with thrombospondin motifs 5; A2AR; adenosine type 2 receptor; Bax; BCL2 associated X protein; Bcl-2; B-cell lymphoma 2; CD44; cluster determinant 44; Col2A; collagen type II alpha; Col1a1; col
TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
Keywords: اینترلوکین 17; TNFα; Th17 cells; Regulatory T cells; Anti-TNF; Interleukin-17;
Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17
Keywords: اینترلوکین 17; SAHH; S-adenosyl-l-homocysteine hydrolase; IMQ; imiquimod; KC; keratinocytes; IL; interleukin; ICAM-1; intercellular adhesion molecule-1; EGFR; epidermal growth factor receptor; MAPKs; mitogen activated protein kinases; ERK; extracellular signal-regulated
The citrus flavanone naringenin reduces gout-induced joint pain and inflammation in mice by inhibiting the activation of NFκB and macrophage release of IL-1β
Keywords: اینترلوکین 17; Naringenin; Gout arthritis; Pain; Inflammation; NFκB; Inflammasome; ABTS; 2,2-azinobis(3-ethylbenzothiazoline-6-sulfonate; ALT; alanine transaminase; ASC; apoptosis-associated speck-like protein containing a CARD; AST; aspartate transaminase; BMDMs; bone
Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?
Keywords: اینترلوکین 17; Interleukin-17; Mechanisms of resistance; Monoclonal antibodies; Polymorphisms; Vascular endothelial growth factor;
Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17â¯T cell subsets and CD4+ T lymphocytes with cytotoxic potential
Keywords: اینترلوکین 17; Rotavirus; VP6; CD4; Cytotoxic T lymphocyte; Interferon-γ; Interleukin-17;
Ablation of interleukin-17 alleviated cardiac interstitial fibrosis and improved cardiac function via inhibiting long non-coding RNA-AK081284 in diabetic mice
Keywords: اینترلوکین 17; Interleukin-17; Diabetic cardiomyopathy; Long noncoding RNA; Interstitial fibrosis;
MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients
Keywords: اینترلوکین 17; MIF; macrophage migration Inhibitory Factor; SLE; Systemic Lupus Erythematosus; rhMIF; recombinant human MIF; PBMC; Peripheral Blood Mononuclear Cells; HS; Healthy Subjects; IFN; Interferon; IL-6; interleukin-6; IL-17; interleukin-17; TNF-α; tumor necros
Nanocrystals of a potent p38 MAPK inhibitor embedded in microparticles: Therapeutic effects in inflammatory and mechanistic murine models of osteoarthritis
Keywords: اینترلوکین 17; PH-797804; Biodegradable microparticles; Nanocrystals; Inflammatory and mechanistic mouse models; Osteoarthritis; Intra-articular administration; Extended drug delivery; p38α/β MAPK inhibitor; 99mTc; technetium-99â¯m; AIA; antigen-induced arthritis; DM
T cells and IL-17 in lupus nephritis
Keywords: اینترلوکین 17; Systemic lupus erythematosus; Lupus nephritis; Interleukin-17; T cells;